2022 August 19, CEO Dr. Bin Xiang presents at the closed door meeting “revolutionary technology in biopharmaceutical industry” in the 24th Shanghai International Forum on Biotechnology & Pharmaceutical Industry.
2022 June 1, CommBio's CEO Dr. Bin Xiang being interviewed by Xinhua News Agency, where he tells the story of how CommBio maintains its high development speed after the challenges posed by COVID.
2022 May 25, CommBio's CEO Dr. Bin Xiang being interviewed by Shanghai TV during quarantine and explains how CommBio, as a small biotech startup focusing on R&D and innovation, is coping with the difficult time.
On September 16, 2021, Dr. Xiang, the founder of CommBio therapeutics, was invited to attend the 5th Annual Cell & Gene Therapy World Asia. In the conference, Dr. Xiang gave a talk on Intestine biology-driven bacterial vector gene therapy.
On April 22-23, 2021, the 8th BioCon 2021 has been held in Shanghai. Dr. Bin Xiang, the founder of CommBio Therapeutics, was invited to attend the conference and gave a talk on Bacterial Vector Gene Therapy in the session of "Gene Therapy and Oncolytic Viral Therapy".
CommBio Therapeutics Co., Ltd 沪ICP备2021004953号-1